Evidence map›Paper›PMID 38916026›Full record

ArticleCureus2024

Thrombocytopenia and Grading of Esophageal Varices in Patients With Chronic Liver Disease.

Muhammad Asad Abbas, Aamir Ali, Saad Bin Zafar, Adeel Ahmed, Muhammad Noman Qureshi, Khizra Hamid, Muhammad Irfan Jamil, Iqra Naeem

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muhammad Asad AbbasGeneral Medicine, Pak Emirates Military Hospital, Rawalpindi, PAK.
Aamir AliGeneral Medicine, Nishtar Medical University, Multan, PAK.
Saad Bin ZafarMedicine and Surgery, King Edward Medical University, Lahore, PAK.
Adeel AhmedMedicine, Lahore General Hospital, Lahore, PAK.
Muhammad Noman QureshiInternal Medicine, Frimley Park Hospital, Camberley, PAK.
Khizra HamidInternal Medicine, Evercare Hospital, Lahore, Lahore, PAK.
Muhammad Irfan JamilNephrology, Lahore General Hospital, Lahore, PAK.
Iqra NaeemPsychiatry and Behavioral Sciences, Lahore General Hospital, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Chronic liver disease (CLD) is associated with a variety of consequences, including thrombocytopenia and esophageal varices, which significantly impact patient prognosis and management. Thrombocytopenia, frequently observed in patients with CLD, may correlate with the severity of esophageal varices, a critical complication leading to variceal bleeding. Methodology A cross-sectional study was carried out in the Department of Medicine and Gastroenterology, Pak Emirates Military Hospital, Rawalpindi, from October 2021 to March 2022. The study enrolled 94 patients, aged 18-70 years, diagnosed with CLD, regardless of the cause. These patients were categorized into four groups based on platelet count: <50,000/uL, 50,000-99,999/uL, 100,000-150,000/uL, and >150,000/uL. Pearson's correlation was utilized to evaluate the association between the severity of thrombocytopenia and the grading of esophageal varices. Results A total of 94 patients were enrolled in the study, with 53 (56.4%) males and 41 (43.6%) females. The mean age of patients was 51.06 ±11.09 years. Seventeen (18.1%) had no esophageal varices, 16 (17.0%) were diagnosed with Grade I varices, 35 (37.2%) with Grade II varices, and 26 (27.7%) had Grade III varices. Most patients without varices had a platelet count above 150 x 10

Indexed as

chronic liver diseaseesophageal variceshbvhcvthrombocytopenia

Identifiers

PMID38916026
PMCPMC11195516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.